Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN107118144A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107118144A details a safer NaBH4-I2 reduction for ezetimibe intermediates, offering high purity and cost reduction in pharmaceutical manufacturing.